English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, July 7, 2023
沛嘉医疗神经介入产品DCwire(TM)微导丝注册申请获药监局批准
沛嘉醫療神經介入產品DCwire(TM)微導絲註冊申請獲藥監局批准
Wednesday, June 14, 2023
沛嘉医疗TaurusTrio经导管主动脉瓣系统获批NMPA创新医疗器械绿色通道
沛嘉醫療TaurusTrio經導管主動脈瓣系統獲批NMPA創新醫療器械綠色通道
Monday, April 3, 2023
沛嘉医疗2022年总收入按年升83.7%
沛嘉醫療2022年總收入按年升83.7%
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022
Monday, March 13, 2023
沛嘉醫療(9996.HK)研發開放日完滿結束。雲集逾300位海內外心臟醫療專家,產品研發取得成就
沛嘉医疗(9996.HK)研发开放日完满结束。云集逾300位海内外心脏医疗专家,产品研發取得成就
Tuesday, September 6, 2022
谁说TAVR风光不再?沛嘉医疗(09996.HK)强势突围!

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575